Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
New medication to prevent colon cancer

New medication to prevent colon cancer

People with diabetes mellitus have three to four times the risk of developing liver cancer

People with diabetes mellitus have three to four times the risk of developing liver cancer

Aspirin might well be considered the top utility player in the medicine cabinet

Aspirin might well be considered the top utility player in the medicine cabinet

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Bladder-sparing treatment shows promise against cancer

Bladder-sparing treatment shows promise against cancer

Benefits of current therapeutic options for pancreatic cancer are eclipsed by their toxicity and inconvenience

Benefits of current therapeutic options for pancreatic cancer are eclipsed by their toxicity and inconvenience

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Pipe smoking as dangerous as cigar smoking

Pipe smoking as dangerous as cigar smoking

Smoking a lot more harmful than previously thought

Smoking a lot more harmful than previously thought

Smoking causes diseases in nearly every organ of the body

Smoking causes diseases in nearly every organ of the body

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

New developments in the treatment of pancreatic cancer

New developments in the treatment of pancreatic cancer

Functional genomics provide improved drug discovery

Functional genomics provide improved drug discovery

Cinnamon's role as an insulin substitute in type II diabetes

Cinnamon's role as an insulin substitute in type II diabetes

Oral chemotherapy agent Orathecin™ (rubitecan) capsules accepted by FDA for filing

Oral chemotherapy agent Orathecin™ (rubitecan) capsules accepted by FDA for filing

Chemotherapy offers new hope for pancreatic cancer patients

Chemotherapy offers new hope for pancreatic cancer patients